ratio

(redirected from benefit-risk ratio)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.

Ratio

The division of one piece of financial information by another. Financial ratios are very common in fundamental analysis, which investigates the financial health of companies. An example of a financial ratio is the price-earnings ratio, which divides a publicly-traded company's share price by its earnings per share. This and other ratios help analysts determine whether a company's share price properly reflects its performance.

ratio

The relation between two quantities when compared mathematically with one another. For example, the most frequently used ratio among investors is the price-earnings ratio. Financial analysts, investors, and managers use ratios to evaluate many factors such as the attractiveness of a stock or the operating efficiency of a company. Also called financial ratio. See also activity ratio, debt management ratio, liquidity ratio, profitability ratio.
References in periodicals archive ?
2004), holds that pesticide testing on human subjects can be conducted, but only under the most stringent scientific and ethical standards, such as favorable benefit-risk ratios, informed consent, equitable subject selection, risk minimization, valid study design, and scientific necessity.
The analysis did provide evidence of a significantly increased rate of edema and, in one study, an increased risk of cardiovascular disease associated with rosiglitazone treatment, leading the researchers to conclude that "the benefit-risk ratio of rosiglitazone therapy in type 2 diabetes mellitus needs urgent clarification.
the potential benefit-risk ratio of levothyroxine therapy justifies its use.
The undue fear and confusion generated in recent years by overrepresentation or misinterpretation of clinical studies mandated a clearer explanation of the therapeutic benefit-risk ratio of HT after menopause, and how these benefits and risks affect both health providers and the women weighing the use of such therapy," said Wulf H.
Rozzo, is that this class of medications has an extremely favorable benefit-risk ratio.